Chemical substances in Batch 10 of the Challenge

Substance Groupings Initiative (2017)

The following four substances in this Batch have been included in the Cobalt-containing Substance Grouping under the Substance Groupings Initiative as part of the second phase of the Chemicals Management Plan (CMP). They were included in the Cobalt-containing Substance Grouping screening assessment to consider exposure to cobalt from multiple cobalt-containing substances. Updated information for these substances is available on the Cobalt-containing Substance Grouping webpage.

List of substances included in the Substance Groupings Initiative
CAS RN Chemical substances Substance Groupings Initiative
7440-48-4 Elemental cobalt Cobalt-containing Substance Grouping
7646-79-9 Cobalt chloride
10124-43-3 Sulfuric acid, cobalt (2+) salt (1:1) (Cobalt sulfate)
10393-49-4 Sulfuric acid, cobalt salt (Cobalt sulfate)

Risk management action milestones

The risk management action milestones table outlines the risk management actions that were proposed for the chemical substance in this batch of the Challenge that met the criteria of section 64 of the Canadian Environmental Protection Act, 1999 (CEPA 1999). These proposed risk management actions were published in the risk management approach document for this substance. For the complete wording of these proposed actions, please refer to the risk management approach document.

Adding substances to Schedule 1

One substance in this batch has been included in a final order to add to Schedule 1.

Applying Significant New Activity provisions

View the Significant New Activity Publications under the Canadian Environmental Protection Act, 1999.

Three substances in this batch were to be addressed through the application of Significant New Activity (SNAc) provisions. One Order and 2 notices of intent have been published. However, further analysis has indicated that due to its chemistry, hydrazine would only be present in a consumer product at low residual levels. As a result, there are no likely new exposure sources of hydrazine for the general population of Canada that would reasonably be suspected to lead to increased risks to human health. Therefore, this risk management instrument to address the human health concerns is no longer being pursued. An order amending the Domestic Substances List (DSL) for hydrazine will not be published. This decision is consistent with the Policy on the use of SNAc provisions of CEPA 1999, published in December 2013. For additional guidance on submitting information required as part of SNAc notifications, please see the Guidelines for the notification and testing of new substances: chemicals and polymers

Summary of Batch 10 substances and publications

Substances that meet one or more criteria in section 64 of CEPA 1999
CAS RN Chemical substance Proposed Order and RIAS Public comments on the proposed risk management approach Final screening assessment Proposed risk management approach Public comments on the draft screening assessment and risk management scope
302-01-2 Hydrazine

HTML

PDF

HTML HTML HTML HTML
Substances that do not meet any of the criteria in section 64 of CEPA 1999
CAS RN Chemical substance Final screening assessment Public comments
330-54-1 Diuron HTML None
7440-48-4Table 3 footnote 1 Elemental cobalt HTML HTML
7646-79-9Table 3 footnote 1 Cobalt chloride
10124-43-3Table 3 footnote 1 Sulfuric acid, cobalt (2+) salt (1:1)
10393-49-4Table 3 footnote 2 Sulfuric acid, cobalt salt
42739-61-7 Nickel BHMB HTML HTML
64365-17-9 HRPE HTML None
65997-06-0 HR
65997-13-9 HRGE
68648-53-3 HRTE
85702-90-5 TIDTE HTML None
124751-15-1 RFBS HTML None
Table 3 footnote 1

These four substances were included in a screening assessment of a broader group of cobalt-containing substances as part of the Substance Groupings Initiative to consider exposure to cobalt from multiple cobalt-containing substances. Updated information for these substances is available on the Cobalt-containing Substance Grouping webpage.

Return to Table 3 footnote 1 referrer

Table 3 footnote 2

Although CAS RN 10393-49-4 is not included in the Challenge, for the purpose of substance identification, two CAS RNs for cobalt sulfate are included in the mandatory section 71 notice (see below). CAS RN 10124-43-3 is used for cobalt (II) sulfate, with a 1:1 cobalt-to-sulfate ratio, and CAS RN 10393-49-4 is used where the specific cobalt ion was not identified, or the ratio between the acid and cobalt is unknown.

Return to Table 3 footnote 2 referrer

Timelines
Date Substances Affected Activity
November 10, 2018 CAS RN 302-01-2 Publication in Canada Gazette, Part I, of a notice requiring the preparation and implementation of pollution prevention plans in respect of hydrazine related to the electricity sector.
Please refer to the Cobalt-containing Substance Grouping web page for timeline information on these four substances. CAS RNs 7440-48-4, 7646-79-9, 10124-43-3, 10393-49-4, as part of the Cobalt-containing Substance Grouping. Various publications in Canada Gazette, including: proposed order adding cobalt and soluble cobalt compounds to Schedule 1 of CEPA 1999, final assessment decisions under subsection 77(6) of CEPA 1999 for cobalt and cobalt-containing substances, and release of Government's Proposed Risk Management Approach Document for Cobalt and Soluble Cobalt Compounds.
April 18, 2015 CAS RN 302-01-2 Publication in Canada Gazette, Part I, and start of 60-day public comment period on the proposed notice requiring the preparation and implementation of pollution prevention plans in respect of hydrazine related to the electricity sector.
March 2, 2013 CAS RN 302-01-2 Publication in Canada Gazette, Part I, of notice of intent to amend the DSL to apply the SNAc provisions of CEPA 1999, and start of 60-day public comment period. This risk management instrument is no longer being pursued (refer to above).
October 10, 2012 CAS RN 302-01-2 Publication in Canada Gazette, Part II, of final order adding 1 substance to Schedule 1.
February 26, 2011 CAS RN 302-01-2 Publication in Canada Gazette, Part I, of proposed order adding 1 substance to Schedule 1, and start of 60-day public comment period.
February 2, 2011 CAS RN 124751-15-1 Publication in Canada Gazette, Part I, of order amending the DSL to apply the SNAc provisions of CEPA 1999.
January 15, 2011 All Batch 10 substances Publication in Canada Gazette, Part I, of final assessment decision under subsection CEPA 1999, release of Government's proposed risk management approach document, and start of 60-day public comment period on the proposed risk management approach document.
January 15, 2011 CAS RN 42739-61-7 Publication in Canada Gazette, Part I, of notice of intent to amend the DSL to apply the SNAc provisions of CEPA 1999, and start of 60-day public comment period.
June 26, 2010 All Batch 10 substances Publication in Canada Gazette, Part I, and start of 60-day public comment period on (a) the draft screening assessment, (b) the new information received, (c) the proposal to pursue one of the measures as specified under CEPA 1999 and (d) the risk management scope document.
June 26, 2010 CAS RN 124751-15-1 Publication in Canada Gazette, Part I, of notice of intent to amend the DSL to apply the SNAc provisions of CEPA 1999, and start of 60-day public comment period.
December 17, 2009 All Batch 10 substances Deadline for submission of additional information by interested stakeholders, including on the extent and nature of the management/stewardship of Batch 10 substances.
October 20, 2009 All Batch 10 substances Deadline for submission of information under the section 71 notice on Batch 10 substances (if no extension granted).
June 20, 2009 All Batch 10 substances Release of Batch 10 of the Challenge and the accompanying technical documents.

Final screening assessments and risk management approaches

In January 2011, the final screening assessments for substances in this batch were released in the Canada Gazette, Part I: Vol. 145, No. 3 - January 15, 2011.

The final screening assessments concluded that 1 substance in this batch meets one or more criteria in section 64 of the CEPA 1999. The Government proposed to add this substance to Schedule 1 of the act. A proposed risk management approach document was also released on this date for the substance in this batch which met the criteria in section 64 of CEPA 1999.

In May 2017, 4 substances in this batch (CAS RNs 7440-48-4, 7646-79-9, 10124-43-3 and 10393-49-4) were included in a screening assessment of a broader group of cobalt-containing substances as part of the Substance Groupings Initiative. The 2017 assessment concluded that cobalt and soluble cobalt compounds are harmful to the environment. Updated information for these substances is available on the Cobalt-containing Substance Grouping web page.

Draft screening assessments and risk management scopes

New information was received from industry or interested stakeholders for each of the 18 substances in this batch. In June 2010, the draft screening assessments were released and the related notices were published in the Canada Gazette, Part I: Vol. 144, No. 26 - June 26, 2010. Risk management scope documents were also released in conjunction with these publications.

Launch of Batch 10 and submissions received

Information on substances in this batch was gathered from industry and interested stakeholders through a mandatory survey notice issued under section 71 of CEPA 1999. They were also invited to complete a voluntary questionnaire.

A notice related to the launch of Batch 10 was published in May 2008 in the Canada Gazette. The section 71 notice applied to all 18 substances in this batch.

Number of submissions received for this Batch
Approximate number Type of response
79 Responses to mandatory section 71 notice (responses were received relating to 11 substances in the batch)
16 Requests for extension of the deadline for section 71 notice responses granted
10 Voluntary submissions of questionnaires (questionnaires were received relating to 7 substances in the batch)
127 Expressions of "stakeholder interest" (responses were received relating to 13 substances in the batch)
32 Other submissions (for example, studies, additional information) (submissions were received relating to 12 substances in the batch)

Page details

Date modified: